KYMR: Kymera Therapeutics Inc

43.70 USD 0.87 (1.95%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do KYMR para hoje mudou para -1.95%. Paralelamente, o preço mais baixo no mercado atingiu 43.21 e o mais alto foi 44.57.

Veja a dinâmica do par de moedas Kymera Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

KYMR Notícias

Zacks 13:54 Kymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock?
Benzinga 12:14 Synovus Financial, Gilead Sciences And More On CNBC's 'Final Trades' - iShares U.S. Financial ETF (ARCA:IYF), Gilead Sciences (NASDAQ:GILD)
Investing 12:55 Kymera Therapeutics stock price target lowered to $65 at Brookline Capital
Investing 08:52 Morgan Stanley initiates Kymera Therapeutics stock with Overweight rating
Investing 07:57 Kymera Therapeutics Q4 2024 slides: immunology pipeline advances with $600M cash infusion
Investing 13:00 Tuesday’s Insider Activity: Major Buys and Sells Shake Up Markets
Investing 22:46 Kymera Therapeutics (KYMR) director group buys $13.9 million in stock
Investing 13:00 Monday’s Insider Activity: Top Buys and Sells in US Stocks
Investing 00:18 Kymera Therapeutics: Baker Bros acquire $28.8m in shares
Investing 14:23 Kymera price target raised to $54 from $51 at BofA on pipeline updates
Investing 13:49 Kymera’s partnerships with Sanofi and Gilead drive value
Investing 04:08 Kymera Therapeutics Announces Pricing of $250 Million Public Offering
Benzinga 13:11 Tesla To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Thursday - Apple (NASDAQ:AAPL), Alnylam Pharmaceuticals (NASDAQ:ALNY)
Investing 12:37 Kymera stock price target raised to $60 from $54 at H.C. Wainwright
Investing 20:52 Kymera Therapeutics price target lowered to $70 at Brookline Capital
Investing 20:17 Kymera Therapeutics launches $250 million public stock offering
Investing 20:13 Kymera Therapeutics stock falls after announcing $250 million offering
Investing 17:30 Kymera stock falls as Jefferies lowers price target on program shifts
Seeking Alpha 17:09 Kymera Shrugs Off Sanofi Bust With Gilead Deal - But There Are Caveats (NASDAQ:KYMR)
Investing 14:09 Kymera stock falls as Sanofi drops IRAK4 degrader for next-gen candidate
Benzinga 13:23 Gilead Bets On Kymera's CDK2 Molecular Glue Degrader For New Cancer Therapies - Gilead Sciences (NASDAQ:GILD), Sanofi (NASDAQ:SNY)
Investing 11:17 Sanofi to advance Kymera’s oral IRAK4 degrader KT-485 to clinical testing
Seeking Alpha 01:14 Tracking Baker Brothers Portfolio – Q1 2025 Update
Investing 21:55 Kymera at Goldman Sachs Conference: Pioneering Oral Protein Degraders

Faixa diária

43.21 44.57

Faixa anual

19.44 53.27

Fechamento anterior: 44.20
Open: 44.57

Bid: 43.70
Ask: 44.00

Low: 43.21
High: 44.57

Volume: 1.523 K

Mudança diária: -1.95%
Mudança mensal: -2.93%

Mudança de 6 meses: 14.40%
Mudança anual: -6.18%

30 julho, quarta-feira